Marker Therapeutics, Inc. (MRKR)

1.435 +0.04 (+3.24%) USD  |  NASDAQ  |  Dec 26, 16:00
1.41 -0.02 (-1.74%) Pre-Market: 08:30
More

Marker Therapeutics Average Basic Shares Outstanding (Quarterly)

Average Basic Shares Outstanding (Quarterly) Chart

View Average Basic Shares Outstanding (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Basic Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Basic Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Basic Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Basic Shares Outstanding (Quarterly) Benchmarks

View Average Basic Shares Outstanding (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade